Kansas City Oncology and Hematology Group

Kansas City, Missouri 64131

0 studies enrolling now · 11 studies all time

What they study most

Adenocarcinoma, Breast Cancer, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Colorectal Neoplasms, Esophageal Neoplasms, Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Hormone-dependent, Non-Small Cell Lung Cancer, Pancreatic Cancer

Studies at this site

• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed
• Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer — Completed
• Study of MDX-010 in Stage IV Breast Cancer — Completed
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients — Completed
• Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma — Completed
• Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma — Completed
• Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer — Completed
• Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer — Stopped early
• Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments — Completed
• Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. — Completed